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INTRODUCTION
Genetic modification of model organisms is a powerful tool 
to study human diseases in vivo. Mice have become the main 
subject of interest for basic researchers because they share 
a broad spectrum of physiological and pathological simi-
larities with humans. These similarities, genetic accessibil-
ity, and a defined genetic background within the laboratory 
mouse strains provide the basis to analyze in vivo cellular 
and molecular pathways that are altered in human diseases. 
Knockout and knockin mice have become valuable tools 
to investigate the role of certain proteins and thereby have 
helped researchers to overcome cause and consequence 
problems arising from biochemical data (Hacking, 2008). For 
biomedical research, the knockin mouse opened the possi-
bility of studying the in vivo pathological consequences of 
gene mutations associated with human disease and examin-
ing their similarity to human pathologies.
Whereas knockout technology aims to delete a gene or 
part of a gene, knockin technology introduces specific muta-
tions or cDNAs into a known locus of the genome. The altered 
mice can then be used to study the molecular mechanisms by 
which specific mutations can contribute to human diseases. 
Examples of the potential of knockin technology are the intro-
duction into mice of human orthologs—the human equiva-
lent of the mouse gene—and investigation into how either 
single-point mutations or gene insertions/deletions/inversions 
observed in human disease affect gene function. In addition, 
knockin technology can be used to introduce reporter genes 
under the control of a cell type–specific promoter to follow 
their fate over time in a defined location within the genome 
(Vorhagen et al., in press). An important advantage of knockin 
technology as compared with integration by chance (random 
integration) is its directed integration into a known locus in the 
genome. By contrast, random integration can result in multi-
ple-copy integration and/or disturbance of genes where the 
transgene was inserted. For example, random integration may 
occur in the promoter of another gene, resulting in disturbed 
transcription of that gene. 
PROCEDURE
The generation of knockin mice utilizes a gene-targeting 
strategy similar to that used for constitutive and condi-
tional knockout mice to modify genes in mouse embryonic 
stem cells. The general procedure of constitutive or tissue-
specific gene targeting in mice was previously described 
BENEFITS OF KNOCKIN TECHNOLOGY
• Exact site of integration is known.
•  Allows functional insight into proteins by studying 
single mutations or human orthologs in vivo.
•  Constitutive, conditional, and inducible gene 
knockins are possible.
•  Knockins can be used to generate mouse models of 
human diseases.
LIMITATIONS
•  Combination of transgenes leads to growing 
complexity, which in turn can lead to more side 
effects.
•  Only very few well-characterized genomic loci like 
the ROSA26  locus that can be used for conditional 
knockin of exogenous genes such as reporters 
or dominant mutations/truncations. This makes 
combinations of reporter and certain transgenes 
knocked in to the same locus difficult. 
• Expensive.
• Time-intensive.
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only one known locus of the genome. One example is the 
introduction of point mutations into an endogenous gene 
through homologous recombination (Figure 1a), which may, 
for example, mimic mutations observed in human condi-
tions. Another example is the targeted insertion of a cod-
ing sequence of interest into the Rosa26 locus, a site that is 
frequently used for targeted transgene expression (Soriano, 
1999). Insertion at this site ensures gene expression under 
the weak local Rosa26 promoter. To date, no disturbances 
of endogenous gene function have been reported on inser-
tion into this locus. An exogenous promoter sequence can 
also be added, leading to enhanced expression of the intro-
duced cDNA. Moreover, when a loxP-flanked stop cassette 
is placed between the promoter and cDNA, the Cre–loxP 
system can be employed for tissue-specific and induced 
expression. In general, the antibiotic resistance–selection 
cassette must be removed to allow the transgene to function 
properly (Figure 1b) (Gunschmann et al., 2014).
Knockin technology can also be used to bring Cre under 
the control of an endogenous promoter (Figure 2a), which can 
then be used to follow the tissue-specific activity of this pro-
moter (see below). One important feature of the knockin tech-
nology is its potential compatibility with inducible systems, 
such as the CreERT and TetO/TetR systems. This compatibil-
ity enables investigators to study the effects of mutations that 
occur in later stages of life, for example—effects that closely 
resemble the cause of many human diseases.
TRANSLATIONAL DISEASE MODELS
Knockin technology allows the generation of mouse models 
that recapitulate human skin diseases (Chen and Roop, 2008). 
One prominent example is a mouse that expressed mutant 
keratin 10 (Fuchs et al., 1992). Mice carrying this mutant K10 
show epidermolytic hyperkeratosis, which closely reproduc-
in two related Research Techniques Made Simple articles 
(Gunschmann et al., 2014; Scharfenberger et al., 2014). In 
brief, the central steps involve isolation and cultivation of 
embryonic stem cells from a blastocyst that are transf ected 
with a targeting construct. This construct integrates into 
genomic DNA directed by homologous sequences flanking 
the construct. Cells are then selected for successful integra-
tion and injected into the cavity of an early embryo. After 
being implanted into a surrogate mother, the embryo devel-
ops into a chimeric mouse in which the transgenic cells 
may have inserted into the germ line. The progeny of these 
mice carry the transgene.
Whereas knockout mouse models target genes to 
delete parts of it (and sometimes the whole gene), knockin 
targeting enables the controlled insertion of genes into 
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Figure 2.  Example of a strategy that uses the knockin technology to 
investigate tissue-specific expression patterns. (a) With the knockin 
technology, a reporter gene (LacZ) is expressed under control of the Rosa26 
promoter restricted by a stop sequence flanked by loxP sites. The Cre 
recombinase under the control of the Tbx18 promoter deletes the stop 
sequence and thereby allows gene expression specifically in Tbx18-positive 
cells. (b–d) The reporter can be used to follow Tbx18 expression in different 
tissues by different methods (X-Gal staining on embryos or tissue sections). 
Adapted from Grisanti et al. (2013).
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Figure 1.  Site-specific integration of a transgene using homologous 
recombination. (a) Generation of a mouse model with a defined point 
mutation within one gene using knockin technology. The target vector 
contains the mutated sequence of the gene of interest (TCA à GCA), as 
well as a resistance cassette. Homologous sequences (HS) mediate the site-
specific integration into the genomic locus. Crossing with a Cre line will 
delete the resistance cassette to ensure that the gene is expressed properly. 
(b) The Rosa26 locus is a widely used locus for transgenic expression. The 
target vector contains the coding sequence (CDS) of interest as well as a 
stop sequence and a resistance cassette flanked by sites of recombination, 
respectively. Removal of the resistance cassette occurs in a separate crossing 
with a Flp-expressing mouse line. Tissue-specific expression of the transgene 
is then achieved by crossing with tissue-specific Cre lines.
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es the phenotype observed in human patients carrying that 
mutation. This knockin mouse model identified suprabasal 
keratins as part of the molecular basis of epidermolytic hyper-
keratosis and provided a basis for studying this human disease 
in vivo and developing approaches for therapy.
Knockin models also create the possibility of examining 
tissues and cells in which a specific promoter is active. For 
example, Grisanti et al. (2013) established a line in which 
Cre was knocked into the locus of the T-box transcription 
factor 18 (Tbx18), such that its expression was under the 
control of the endogenous Tbx18 promoter. In combination 
with a β-galactosidase reporter knockin, Tbx18 was shown 
to be active in dermal papilla precursor cells and thus was 
identified as a marker for these cells (Figure 2) (Grisanti et 
al., 2013).
KNOCKIN TEChNOLOGY: LIMITATIONS
Knockin models exhibit great potential for the analysis of 
biological processes and disease mechanisms, but several 
limitations still exist. Most are shared with the limitations of 
knockout models that are described elsewhere (Gunschmann 
et al., 2014; Scharfenberger et al., 2014). One potential 
limitation includes artifacts resulting from the forced over-
expression of a gene, resulting in unspecific protein–protein 
interactions, for example. Perhaps the biggest disadvantage 
is that mouse physiology is not identical to that of humans. 
Using human orthologs of proteins to generate “humanized” 
mouse models for diseases therefore does not entirely reflect 
a human pathological situation. 
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1.  The knockin of a transgene is ________  
with ________
A. Site specific; one integration.
B. Random; one integration.
C. Random; multiple integrations.
2.  The knockin can be combined with which  
of the following?
A.  Only tissue-specific expression systems.
B.  Only inducible expression systems.
C.  Tissue-specific and inducible expression  
systems.
D.  A constitutive expression system only.
3.  The tissue-specific expression of a transgene relies 
on which of the following?
A. Promoter specificity.
B. Tissue-specific Cre expression.
C.  Administration of tamoxifen.
4. Site-specific integration has what advantage?
A.  Effects on other genes are minimized.
B.  The transgene is always expressed.
C.  The transgene cannot be lethal.
5.  Site specific integration of a human gene allows 
investigators to do which of the following?
A. Study common mouse diseases.
B. Investigate mechanisms of human diseases.
C.  Identify interaction partners on a protein level.
QUESTIONS
This article has been approved for 1 hour of Category 1 CME credit.  
To take the quiz, with or without CME credit, follow the link under  
the “CME ACCREDITATION” heading.
